Mangoo-Karim R, Ye M, Wallace D P, Grantham J J, Sullivan L P
Department of Medicine, University of Kansas Medical Center, Kansas City 66160-7401, USA.
Am J Physiol. 1995 Sep;269(3 Pt 2):F381-8. doi: 10.1152/ajprenal.1995.269.3.F381.
We have investigated the hypothesis that active anion transport drives fluid secretion by the cystic epithelium in autosomal dominant polycystic kidney disease (ADPKD). We prepared monolayers of a primary culture derived from cystic tissue removed from ADPKD patients. The monolayers were grown on permeant supports, and fluid secretion was initiated by forskolin. The results were compared with those obtained with monolayers of Madin-Darby canine kidney (MDCK) cells, known to secrete Cl-. In the absence of the agonist, ADPKD monolayers absorbed fluid (0.20 +/- 0.02 microliter.cm surface area-2.h-1). Forskolin reversed this to secretion (0.60 +/- 0.03 microliter.cm-2.h-1). Control MDCK monolayers did not transport fluid in either direction, but forskolin induced secretion (0.48 +/- 0.03 microliter.cm-2.h-1). The electrical properties of the monolayers were monitored in Ussing chambers. Forskolin increased the transepithelial potential difference (Vte) of ADPKD monolayers (-0.9 +/- 0.1 to -1.1 +/- 0.1 mV) and the short-circuit current (Isc) (6.6 +/- 0.7 to 9.2 +/- 0.8 microA/cm2). The transepithelial resistance (Rte) fell (156 +/- 9 to 138 +/- 10 omega.cm2). Similar results were obtained with MDCK monolayers. The polarity of Vte and the direction of the Isc are compatible with the hypothesis that active secretion of anion drives fluid secretion. Basolateral application of the Na-K-2Cl cotransporter, bumetanide, reduced forskolin-stimulated fluid secretion by ADPKD monolayers (0.56 +/- 0.05 to 0.28 +/- 0.03), depolarized Vte, and inhibited Isc without affecting Rte. Apical application of the Cl- channel blocker, diphenylamine-2-carboxylate, also inhibited fluid secretion by ADPKD monolayers (0.65 +/- 0.03 to 0.27 +/- 0.02 microliter.cm-2.h-1).(ABSTRACT TRUNCATED AT 250 WORDS)
在常染色体显性遗传性多囊肾病(ADPKD)中,活性阴离子转运驱动囊性上皮细胞分泌液体。我们制备了源自ADPKD患者切除的囊性组织的原代培养单层细胞。这些单层细胞生长在可渗透的支持物上,并用福斯高林启动液体分泌。将结果与已知分泌氯离子的Madin-Darby犬肾(MDCK)细胞单层细胞的结果进行比较。在没有激动剂的情况下,ADPKD单层细胞吸收液体(0.20±0.02微升·厘米表面积-2·小时-1)。福斯高林将其转变为分泌(0.60±0.03微升·厘米-2·小时-1)。对照MDCK单层细胞在两个方向上都不转运液体,但福斯高林诱导分泌(0.48±0.03微升·厘米-2·小时-1)。在尤斯灌流小室中监测单层细胞的电特性。福斯高林增加了ADPKD单层细胞的跨上皮电位差(Vte)(从-0.9±0.1到-1.1±0.1毫伏)和短路电流(Isc)(从6.6±0.7到9.2±0.8微安/平方厘米)。跨上皮电阻(Rte)下降(从156±9到138±10欧姆·厘米2)。MDCK单层细胞也得到了类似结果。Vte的极性和Isc的方向与阴离子的活性分泌驱动液体分泌这一假说相符。在基底外侧应用钠钾氯协同转运体抑制剂布美他尼,可减少福斯高林刺激的ADPKD单层细胞的液体分泌(从其0.5±0.05到0.28±0.03),使Vte去极化,并抑制Isc,而不影响Rte。在顶端应用氯离子通道阻滞剂二苯胺-2-羧酸盐,也可抑制ADPKD单层细胞的液体分泌(从0.65±0.03到0.27±0.02微升·厘米-2·小时-1)。(摘要截短于250字)